pulmonary infections
DESCRIPTION
Pulmonary Infections. Amar Safdar, MD, FACP Associate Professor of Medicine M. D. Anderson Cancer Center. BACKGROUND Community-Acquired Pneumonia. Incidence 2 to 12 cases per 1,000 population per year 600,000 admissions per year 4,200,000 inpatients days Annual cost > $8.4 billion - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/1.jpg)
Pulmonary Infections
Amar Safdar, MD, FACP
Associate Professor of Medicine
M. D. Anderson Cancer Center
![Page 2: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/2.jpg)
BACKGROUND Community-Acquired Pneumonia
![Page 3: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/3.jpg)
• Incidence 2 to 12 cases per 1,000 population per year
• 600,000 admissions per year
• 4,200,000 inpatients days
• Annual cost > $8.4 billion– Mostly associated with extended length of
hospital stay [LOS]– Recently, guidelines and/or standardized
order sets (SOSs) used by intensive clinical case management (ICCM) substantially reduced LOS while maintaining quality of care.
Fishbane S, et al. Arch Intern Med 2007;167:1664–1669.
![Page 4: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/4.jpg)
Pneumonia Severity Index (PSI)
Multivariate analysis
Age > 80 yr 0.09 0.04–0.21 < 0.001
Liver cirrhosis 2.60 1.05–6.42 0.038
Diabetes 2.81 1.36–5.79 0.005
Creatinine level > 1.6 mg/dL 1.24 1.04–1.47 0.012
PaO2/FIO2 ratio < 250 2.58 1.24–6.10 0.002
Diastolic BP < 60 mm Hg 2.76 1.2–3.9 0.012
pH < 7.35 4.57 2.50–8.34 < 0.001
• The mortality rate was higher in ICU vs. non-ICU patients (37% vs. 20%, respectively; p = 0,003). – A low level of consciousness (OR, 3.95; 95% CI, 2 to 5) – Shock (OR, 24.7; 95% CI, 14 to 44) were associated with
a higher risk of death.
The modified ATS severity rule had the best accuracy in predicting ICU admission and mortality.
Valencia M, et al. Chest 2007;132:515–522.
![Page 5: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/5.jpg)
Etiology of Community-Acquired Pneumonia Among Patients who Require Hospitalization
![Page 6: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/6.jpg)
Organisms Overall (n = 457)
Non-ICU Patients(n = 365)
ICU Patients(n = 92)
Positive isolates, No. 203 139 64
S pneumoniae 101 (49.7) 71 (51.1) 30 (46.8)
P aeruginosa 24 (11.8) 14 (10.1) 10 (15.6)
Haemophilus influenzae 22 (10.8) 16 (11.5) 6 (9.3)
Legionella pneumophila 10 (4.9) 7 (5) 3 (4.6)
Staphylococcus aureus 6 (2.9) 2 (1.4) 4 (6.2)
Escherichia coli 13 (6.4) 10 (7.2) 3 (4.6)
Moraxella catharralis 2 (1) 1 (< 1) 1 (1.5)
Chlamydia pneumoniae 5 (2.4) 4 (2.9) 1 (1.5)
Mycoplasma pneumoniae 3 (1.5) 3 (2.1)
Coxiella burnetti 2 (1) 1 (< 1) 1 (1.5)
Virus 10 (4.9) 7 (5) 3 (4.6)
Others 7 (3.4) 3 (2.1) 4 (6.2)
Polymicrobial 22 (10.8) 10 (7.2) 12 (18.7)
![Page 7: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/7.jpg)
CAP Treatment Response
![Page 8: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/8.jpg)
Treatment of Community-Acquired Pneumonia
• A pathogen directed treatment (PDT) approach compared with an empirical broad spectrum antibiotic treatment (EAT) strategy.– No significant differences were found between the
two treatment groups in LOS, 30 day mortality, clinical failure, or resolution of fever.
– Side effects, occurred more frequently in patients in the EAT group than in those in the PDT group (60% v 17%, 95% CI –0.5 to –0.3; p<0.00).
Van der Eerden MM, et al. Thorax 2005;60:672–678.
![Page 9: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/9.jpg)
Long-Term Follow up of Patients with Community-Acquired Pneumonia
![Page 10: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/10.jpg)
• In this case-control study of Medicare patients with CAP, with five control subjects matched for age, sex, and race with each case, the in-hospital and 1-year mortality rates for patients with CAP were significantly higher than those for control subjects.
Kaplan, V, et al. Arch Intern Med 2003; 163,317-323
![Page 11: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/11.jpg)
Current CAP Core Measures for Admitted Patients
• First dose of antibiotics within 4 h of arrival to hospital• Oxygenation assessment within 24 h of hospital admission• Correct antibiotic for admitted patients Non-ICU • ICU – Includes no monotherapy• Blood cultures within 24 h for all patients admitted to ICU in
first 24 h • Blood for cultures drawn prior to antibiotics administration for
those drawn in emergency department• Evaluation and offering of pneumococcal and influenza
vaccination• Smoking cessation advice
Niederman MS. Am J Med 2004;117:51S–57S.
![Page 12: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/12.jpg)
BACKGROUNDHealthcare-Associated Pneumonia
![Page 13: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/13.jpg)
Pieracci EM, et al. Am Surg 2007:73:419–432.
![Page 14: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/14.jpg)
![Page 15: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/15.jpg)
Community–Acquired MRSA
![Page 16: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/16.jpg)
Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in the United States. MRSA rates are according to US Census Bureau Regions. Data are cumulative data from 1998 to March 2005. IP, inpatient; OP, outpatient. Adapted from Styers et al.
![Page 17: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/17.jpg)
SCCmec 4 Subtypes:[mecA gene located on a mobile cassette chromosome]
• HA-MRSA – subtype I–III
• CA-MRSA – subtype IV–V
![Page 18: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/18.jpg)
Kahl BC, Peters G. Science 2007;315:1082–1083.
![Page 19: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/19.jpg)
In a retrospective study conducted in the United States and taken from a large multi-institutional database examined rates of CAP, HCAP, ventilator-associated pneumonia, and HAP.
Approximately 50% of patients had CAP and more than 20% had HCAP, with S aureus being a major causative pathogen.
Kollef MH, et al. Chest. 2005;128;6:3854-3862.
![Page 20: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/20.jpg)
• Results of nonbronchoscopic BAL fluid cultures collected within 4 h of ICU admission in 95 elderly nursing-home patients with aspiration pneumonia admitted to the ICU. The dominant organism group was enteric Gram-negative pathogens, and anaerobes were less common and often part of a mixed infection.
El Solh, AA, et al. Am J Respir Crit Care Med 2003;167,1650-1654
![Page 21: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/21.jpg)
Stenotrophomonas maltophilia pneumonia
• Patients at risk for developing Stenotrophomonas maltophilia pneumonia:– Critical Care Unit stays– Mechanical ventilation– Neutropenia
Aisenberg G, et al. Eur J Clin Microbiol Infect Dis 2007;26:13-20.
• Non-neutropenic, non-ICU cancer patients (Cases) with S. maltophilia pneumonia, compared with neutropenic, non-ICU patients had [1997-2004]:– Higher exposure to carbapenem antibiotics (58 vs. 41%; p <
0.03)– More frequent hematologic malignancy (95 vs. 64%; p <
0.0003)– Presented with concurrent bacteremia more often (23 vs. 0%; p
< 0.0005).
![Page 22: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/22.jpg)
– Hospital-acquired S. maltophilia pneumonia was more common among neutropenic or ICU patients than non-neutropenic, non-CCU cancer patients (98 vs. 61%; p < 0.000002).
– Among the cases: 34% received outpatient oral antimicrobial therapy and 28% were admitted to the ICU.
– The mean duration of ICU stay, even among these eight patients (19 +/- 40 days), was comparable to that of patients with neutropenia (23 +/- 26 days) and those who developed S. maltophilia pneumonia during their ICU stay (34 +/- 22 days; p = 0.46).
– The overall infection-associated mortality in the 108 cancer patients with S. maltophilia pneumonia was 25%.
– 20% of patients without traditional risk factors for S. maltophilia pneumonia died due to progressive infection.
– In a multivariate logistic regression analysis, only admission to the ICU predicted death (odds ratio 33; 95% confidence interval, 4.51-241.2; p < 0.0006). The results of this study indicate S. maltophilia pneumonia is a serious infection even in non-neutropenic, non-ICU patients with cancer
Aisenberg G, et al. Eur J Clin Microbiol Infect Dis 2007;26:13-20.
![Page 23: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/23.jpg)
Ventilator-Associated Pneumonia
![Page 24: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/24.jpg)
Pieracci EM, et al. Am Surg 2007:73:419–432.
![Page 25: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/25.jpg)
Pieracci EM, et al. Am Surg 2007:73:419–432.
![Page 26: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/26.jpg)
Clinical Pulmonary Infection Score (CPIS)
• Temperature• Leukocyte count• CXR infiltrates• Volume of tracheal secretions• PaO2:FIO2• Culture and GS of tracheal aspirate
[0-2 points each yields 12 points; > 6 points indicates high probability of VAP]
The National Nosocomial Infection Surveillance system diagnostic criteria for nosocomial pneumonia
The negative predictive value of a GS showing no organisms in a clinically stable patient approaches 100%
![Page 27: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/27.jpg)
J Trauma 2007;62:1377–1383.
![Page 28: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/28.jpg)
J Trauma 2007;62:1377–1383.
![Page 29: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/29.jpg)
Pieracci EM, et al. Am Surg 2007:73:419–432.
![Page 30: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/30.jpg)
HAP/ VAP OUTBREAKSMULTIDRUG RESISTANT [MDR] ORGANISMS
![Page 31: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/31.jpg)
Large outbreak of infection due to clonal Multidrug-Resistant Acinetobacter baumannii caused significant morbidity and expense. Aerosolization of MDR A. baumannii during pulsatile lavage debridement of infected wounds and during the management of respiratory secretions from colonized and infected patients may promote widespread environmental contamination.
Young LS, et al. Infect Control Hosp Epidemiol 2007
![Page 32: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/32.jpg)
• Infection control measures included the following: – Limitations on the performance of pulsatile lavage
wound debridement– The removal of items with upholstered surfaces– The implementation of contact isolation for patients
with suspected MDR A. baumannii infection.
![Page 33: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/33.jpg)
CONTROL HAP OUTBREAKS
Multifaceted infection control interventions decrease spread and colonization/infection due to MDR organisms among hospitalized patients.
![Page 34: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/34.jpg)
The current recommendations for empirical antibiotic treatment of hospital-acquired pneumonia (American Thoracic Society and Trouillet) showed a good ability to predict the involved pathogen.
• The ATS and Trouillet antibiotic treatment recommendations were adequate in 79% and 80% of the patients, respectively.
• The microorganisms implicated in the treatment inadequacy of the ATS guideline were Pseudomonas aeruginosa, Acinetobacter baumanii, Stenotrophomonas maltophilia and methicillin-resistant Staphylococcus aureus.
• The main reason was the failure to treat highly resistant strains.
![Page 35: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/35.jpg)
![Page 36: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/36.jpg)
Viral Pulmonary Infections
![Page 37: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/37.jpg)
• Respiratory Viruses– Influenza virus – Parainfluenza virus– Respiratory syncytial virus– Adenovirus – Metapneumonvirus
Increasing Drug-Resistant H5N1
![Page 38: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/38.jpg)
![Page 39: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/39.jpg)
POSTVIRAL SUPERINFECTIONS
• Streptococcus pneumoniae
• Staphylococcus aureus
• Pseudomonas spp.
• Stenotrophomonas maltophilia
• Fungal infections
![Page 40: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/40.jpg)
CONCLUSIONS
• CAP and HAP leads to serious morbidity and substantially increases healthcare cost.
• Inappropriate/discordant antimicrobial therapy increases risk of complications, prolongs hospital stay, treatment failure and death.
• In most patients, inappropriate therapy is given for pulmonary infections due to MDR organisms.
• Effective, multifaceted infection control surveillance and infection control measures are pivotal in reducing the risk of these life-threatening infections.
![Page 41: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/41.jpg)
![Page 42: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/42.jpg)
![Page 43: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/43.jpg)
Pieracci EM, et al. Am Surg 2007:73:419–432.
![Page 44: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/44.jpg)
MYCOBACTERIAL INFECTIONS
![Page 45: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/45.jpg)
Tuberculosis Background
• 8 million new cases of M. tuberculosis are estimated to occur yearly adding to the existing burden of 1.7 billion cases worldwide [One-third of worlds population is now estimated to be infected with this potentially devastating infection]
• In 1993, the World Health Organization declared tuberculosis as public health emergency, as 3 million patients were expected to die annually due to complications arising from tuberculosis, making it the most frequent cause of death due to an infectious organism.
• Man is the only known reservoir of M. tuberculosis.
![Page 46: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/46.jpg)
Background• In the US, reported M. tuberculosis declined during the 20th
century until 1985. • The unanticipated rise in the newly diagnosed cases
between 1985 and 1992 was attributed to HIV-AIDS, illicit drug use, homelessness, and ineffective tuberculosis control programs in the large urban centers.
• Since 1992, the decline in M. tuberculosis cases was attributed to re-implementation of effective public health surveillance `programs with emphasis on 1) early diagnosis (interrupt infection transmission in the community), and 2) DOT (ensured compliance of adequate anti-tuberculosis therapy).
• These measures led to the lowest ever recorded new tuberculosis cases in 1997.
![Page 47: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/47.jpg)
Risk Factors
In the developing world• Protein-calorie malnutrition. • Residents of overcrowded communities with
inadequate sanitation, and poor-ventilation. • Silicosis.• HIV-AIDS, which has now replaced
Mycobacterium tuberculosis as the most common cause of death due to a single infectious agent.
![Page 48: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/48.jpg)
Risk FactorsIn the developed world• HIV-AIDS.• Homelessness, stay in homeless shelters.• Illicit drug use.• Incarceration in correctional facilities.• Nursing home residents.• Silicosis.• Substantial rapid weight loss.• Previous gastrectomy.• Prolonged systemic corticosteroids (> 15 mg prednisone/day).• Chronic end-stage renal disease. • Tumor necrosis factor inhibitor therapy for rheumatoid
arthritis such as Infliximab, Adalimumab, etc.
![Page 49: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/49.jpg)
Risk Factors• Cancer: Hodgkin’s Disease, gastric, head and neck
malignancies. We have recently described patients with AML, CML, and NHL also at risk for developing tuberculosis. [0.2/1000 new cancer diagnosis, 1.3/1000 new leukemia diagnosis]
• Organ-transplant recipients have higher rate of infection compared with patients undergoing HSCT.
• Patients undergoing HSCT in high M. tuberculosis endemic areas have increased risk of infection.
• In the US, M. tuberculosis reactivation remains a concern in foreign-born patients undergoing immunosuppressive antineoplastic therapy.
De La Rosa De La Rosa et alet al. Eur J Clin Microbiol Infect Dis 2004;10:749-52.. Eur J Clin Microbiol Infect Dis 2004;10:749-52.
![Page 50: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/50.jpg)
Diagnosis of Active Tuberculosis of Active Tuberculosis
![Page 51: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/51.jpg)
Diagnosis of Active Tuberculosis
![Page 52: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/52.jpg)
Nontuberculous Pulmonary Mycobacteriosis
• Mycobacterium avium intracellulare complex (MAC)
• Men age 50 to 75 years, chronic smoker, and have chronic obstructive pulmonary disease (COPD)
• Hot tub use [hypersensitivity pneumonitis]
Marchetti N, et al. Lung 2004;182:271–277.
![Page 53: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/53.jpg)
• Women age 30 to 70 years.
• Bronchiectasis, scoliosis, mitral valve prolapse, and pectus excavatum deformity [Lady Windermere Syndrome]
• Interferon-gamma defect
• High rates of treatment refractory disease and infection relapse after therapy is discontinued
Safdar A, et al. American Journal of Medicine 2002;113:756–759.Safdar A, et al. Annals of Internal Medicine 2003;138:521.
Nontuberculous Pulmonary Mycobacteriosis
![Page 54: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/54.jpg)
Fungal Lung Infections
![Page 55: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/55.jpg)
![Page 56: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/56.jpg)
Fungal conidia
Entrapped in mucus
Non-cellularDefense peptides(ALP, TAP,
Lysozyme)
Sp-A/DsIgA, CRPopsonization
Complementopsonization
Monocytes/Aveolar M
Lung parenchyma
PMN
Platelets
Cytokine production andrecruitment of
Inflammatory cells
![Page 57: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/57.jpg)
Fungal conidia
Entrapped in mucus
Sp-A/DsIgA, CRPopsonization
ComplementopsonizationMonocytes/
Aveolar M
Lung parenchyma
PMN
Cytokine production andrecruitment of
Inflammatory cells
Conidial IFAFD
Conidial IFSODToxinsProteases
Chemotherapy-Induced damage of Respiratory epithelium
![Page 58: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/58.jpg)
Dendritic cell
Migration to spleen/Other lymphoid organs
Blood vessel
Dissemination
Cytokine production andrecruitment of
Inflammatory cells
Hemorrhage/Necrosis
![Page 59: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/59.jpg)
Blood vessel
Dissemination
Cytokine production andrecruitment of
Inflammatory cells
Hemorrhage/Necrosis
Angioneogenesis?
Migration to spleen/Other lymphoid organs
![Page 60: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/60.jpg)
Refractory, Relapsed CLL Following Allogeneic HSCT
![Page 61: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/61.jpg)
![Page 62: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/62.jpg)
![Page 63: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/63.jpg)
Antifungal Therapy
• Reducing causative immune defect– Resolution of neutropenia– Resolution of GVHD
• Immune enhancement strategies– Donor granulocyte transfusions– Recombinant cytokines: GM-CSF, Interferon-gamma
• Antifungal drugs – Triazoles: Voriconazole, Posaconazole– Echinocandins: Caspofungin, Micafungin, Anidulafungin
Safdar A. Bone Marrow Transplantation 2006;Safdar A, et al.
![Page 64: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/64.jpg)
Community-Acquired MRSA is Associated With High Prevalence of PVL Toxin
PVL is a pore forming exotoxin complex (LukSPV + LukFVP) that causes leukocyte destruction and tissue necrosis.
• It is present in 2% of S aureus clinical isolates, PVL positive MRSA infections are prevalent in several clinical settings:
–PVL genes are detected in virtually all community-acquired furunculosis infections
–PVL MRSA is associated with severe necrotic hemorrhagic pneumonia in adults and children
Zetola N et al. Lancet Infect Dis. 2005;5:275-286.Gillet Y et al. Lancet. 2002;359:753-759.
Gonzalez BE et al. Clin Infect Dis. 2005;41:583-590.
![Page 65: Pulmonary Infections](https://reader030.vdocuments.us/reader030/viewer/2022012905/56813c8c550346895da6328c/html5/thumbnails/65.jpg)
Lowy FD. N Engl J Med 1998;339:520.